Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
original academic
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Original Academic (Shanghai) Biotechnology, also known as Yuanxue Biotech, is a clinical-stage biotechnology company specializing in mRNA-based therapeutics and vaccines. Based in Shanghai, the company leverages a proprietary mRNA-LNP (lipid nanoparticle) delivery platform to develop treatments for infectious diseases and oncology. Its lead program is an mRNA vaccine candidate for COVID-19, which has progressed into clinical trials in China. Original Academic focuses on optimizing mRNA sequence design and delivery systems to improve the stability and efficacy of its candidates. The company is part of a new wave of Chinese biotechs advancing domestic mRNA technology. It aims to provide innovative solutions for global health challenges through its integrated R&D and manufacturing capabilities.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- mRNA-based drugsLipid nanoparticle delivery therapyVaccineRNA therapy
- Industry
- Biotech
Beyond the preview
Go deeper on original academic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on original academic.